Insurers won't cover new Alzheimer's treatment for some customers
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s pati...
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s pati...
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening
U.S. health advisers are backing the full approval of an Alzheimer's drug that received preliminary approval last year
Eli Lilly and Co. says its experimental Alzheimer's drug appears to slow worsening of the mind-robbing disease
The sons of cosmetics giant Estée Lauder, along with her four grandchildren, pledged $200 million Tuesday to the Alzheim...
Scientists are digging into why a few people escape the rarest form of Alzheimer's, which is inherited and strikes young
The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months awa...
The FDA has granted accelerated approval to a new Alzheimer's drug.
Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. sai...
Biogen is slashing the price of its Alzheimer’s treatment months after the drug debuted to widespread criticism for an i...